Leishmania Antibody, IgG (Visceral Leishmaniasis)
Also known as: LEISH IGG
Use
The detection of IgG antibody directed at Leishmania helps in the diagnosis of leishmaniasis. It can suggest either a current or past infection, providing clinicians with vital information regarding the patient's exposure to the parasite responsible for visceral leishmaniasis, including conditions such as Kala Azar.
Special Instructions
The test is conducted using a serum specimen collected in a serum separator tube. Post-collection, the serum needs to be transferred to an ARUP standard transport tube with a preference for a minimum volume of 0.5 mL, but not less than 0.1 mL. The specimen should be frozen for transport to ensure stability.
Limitations
This test specifically detects IgG antibodies directed at Leishmania, which may indicate a current or past infection but does not distinguish between active and past infections. Hemolyzed specimens or those containing glycerol or other viscous materials are unacceptable and could result in erroneous results.
New York Approved
Methodology
Immunoassay (Qualitative Immunoassay)
Biomarkers
LOINC Codes
- 35402-7
- 35402-7
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.1 mL
Container
ARUP standard transport tube
Collection Instructions
Collect serum in a serum separator tube and transfer to a transport tube.
Storage Instructions
Keep the specimen frozen until transported.
Causes for Rejection
Serum containing glycerol or other viscous materials. Hemolyzed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant